Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

Published:2022-12-22 Issue:4 Volume:53 Page:301-311
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Tahata Yuki¹,Sakamori Ryotaro¹^ORCID,Maesaka Kazuki¹,Doi Akira¹,Yamada Ryoko¹,Kodama Takahiro¹^ORCID,Hikita Hayato¹^ORCID,Miyazaki Masanori²,Nozaki Yasutoshi³,Kaneko Akira⁴,Oshita Masahide⁵,Tanaka Satoshi⁶,Imanaka Kazuho⁷,Hiramatsu Naoki⁸,Morishita Naoki⁹,Ohkawa Kazuyoshi¹⁰^ORCID,Yakushijin Takayuki¹¹,Sakakibara Mitsuru¹²,Iio Sadaharu¹³,Doi Yoshinori¹⁴,Tatsumi Tomohide¹,Takehara Tetsuo¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita, Osaka Japan

2. Osaka Police Hospital Osaka Japan

3. Kansai Rosai Hospital Amagasaki, Hyogo Japan

4. Japan Community Healthcare Organization Osaka Hospital Osaka Japan

5. Ikeda Municipal Hospital Ikeda, Osaka Japan

6. National Hospital Organization Osaka National Hospital Osaka Japan

7. Itami City Hospital Itami, Hyogo Japan

8. Osaka Rosai Hospital Sakai, Osaka Japan

9. Minoh City Hospital Minoh, Osaka Japan

10. Osaka International Cancer Institute Osaka Japan

11. Osaka General Medical Center Osaka Japan

12. Yao Municipal Hospital Yao, Osaka Japan

13. Hyogo Prefectural Nishinomiya Hospital Nishinomiya, Hyogo Japan

14. Otemae Hospital Osaka Japan

Funder

Gilead Sciences

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13868

Reference43 articles.

1. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

2. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

3. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

4. Characteristics of patients aged over 75 years with hepatitis C virus infection treated with direct‐acting antivirals in Japan: Evidence based on the nationwide, real‐world database in Japan

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma;Hepatology Research;2024-07-29

2. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years;Gastroenterología y Hepatología;2024-05

3. Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study;JGH Open;2024-04

4. VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis;Digestive Diseases and Sciences;2024-01-20

5. Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus;Journal of Gastroenterology;2023-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3